<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Hemolytic Disorders: Sickle Cell, Thalassemia, and Aplastic Anemia</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="hematology-anaemias.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 57%;"></div> <!-- Set percentage dynamically -->
                        </div>
                       <span class="progress-text">Lecture 4 of 7</span> <!-- Update text -->
                    </div>
                    <a href="hematology-bleeding-disorders.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">Hemolytic Disorders</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                <!-- START: haemolytic-anaemia -->
                <section id="haemolytic-anaemia" class="content-section" aria-labelledby="section-heading-1">
                    <h2 id="section-heading-1" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Haemolytic anaemia</span>
                    </h2>
                    <div class="content-card">
                        <p>Red blood cells have a lifespan of 120 days. In hemolytic state lifespan shortens causing anaemia. However, the body has compensatory measure, thus the bone marrow increases the RBC production. If the BM cannot cope up with the RBC destruction, then the haemolytic state can exist, without anaemia. Thus anaemia results when the BM can no longer compensate for lost cells. The rate of destruction exceeds production.</p>
                        <p>This increased output of cells causes outpouring of high reticulocytes into the blood stream.</p>
                        <p>Abnormally rapid breakdown of RBC causes;</p>
                        <ul>
                            <li>Serum bilirubin level to increase</li>
                            <li>Jaundice</li>
                            <li>Increased urinary excretion of urobilinogen.</li>
                        </ul>

                        <h3 class="subsection-heading">Sites of haemolysis</h3>
                        <ol>
                            <li><strong>intravascular</strong> - RBC are rapidly destroyed in circulation & haemoglobin is released and becomes bound to haptoglobin forming a large complex which can not be excreted by the kidneys instead it is taken to the liver for storage and removal. If all haptoglobin is released, then Haemoglobin is excreted in urine (haemoglobinuria) these leads to passage of black urine.</li>
                            <li><strong>Extravascular</strong> - RBC are destroyed in liver, spleen & BM. If haemolysis is chronic the organ involved will hypertrophy. Consequently in long term haemolysis the liver& spleen enlarge.</li>
                        </ol>

                        <h3 class="subsection-heading">Causes of haemolysis</h3>
                        <ol>
                            <li><strong>Inherited</strong>, this includes;
                                <ul>
                                    <li>i) Rbc membrane defects e.g. hereditary spherocytosis, hereditary elliptocytosis.</li>
                                    <li>ii) Hb abnormalities e.g. sickle cell anaemia & thelassaemia.</li>
                                    <li>ii) Metabolic defects e.g. G6PD, pyruvate kinase deficiency.</li>
                                </ul>
                            </li>
                            <li><strong>Acquired</strong>, this includes;
                                <ul>
                                    <li>i) Immunological e.g.
                                        <ul>
                                            <li>a) auto immune disease ( autoimmune hemolytic anaemia)</li>
                                            <li>b) Iso immune disease</li>
                                            <li>c) Drugs e.g. penicillin</li>
                                        </ul>
                                    </li>
                                    <li>ii) Non immunological e.g.
                                        <ul>
                                            <li>a) Rbc membrane defects e.g. paroxysmal nocturnal haemoglobinuria .</li>
                                            <li>b) Renal & liver disease</li>
                                            <li>c) Mechanical disorders e.g. damage to blood vessel, valve prosthesis. These may break up normal RBCs</li>
                                        </ul>
                                    </li>
                                    <li>iii) Miscellaneous causes e.g.
                                        <ul>
                                            <li>a) Infections like malaria.</li>
                                            <li>b) Drugs & chemicals</li>
                                            <li>c) Hypersplenism. Enlarged spleen traps and destroy RBCs</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                        </ol>

                        <h3 class="subsection-heading">Clinical features of HA</h3>
                        <ul>
                            <li>a) General symptoms of anaemia.</li>
                            <li>b) Jaundice.</li>
                            <li>c) Dark urine</li>
                            <li>d) Enlarged spleen.</li>
                            <li>e) Abdominal pains</li>
                        </ul>

                        <h3 class="subsection-heading">Investigation</h3>
                        <ol>
                            <li>Blood for full haemogram.
                                <ul>
                                    <li>Hb level low</li>
                                    <li>Raised reticulocyte count.</li>
                                    <li>Cells are usually normocytic though there may be macrocytic.</li>
                                </ul>
                            </li>
                            <li>Urinalysis: Haemoglobilirunogen (haemoglobinuria), Urobilirunogen</li>
                            <li>Serum - bilirubin elevated</li>
                            <li>BM aspirate - There is erythroid hyperplasia (high RBC precursors).</li>
                        </ol>
                    </div>
                </section>
                <!-- END: haemolytic-anaemia -->

                <!-- START: haemoglobin-abnormalities -->
                <section id="haemoglobin-abnormalities" class="content-section" aria-labelledby="section-heading-2">
                    <h2 id="section-heading-2" class="section-heading">
                         <span class="heading-icon"> </span>
                         <span class="heading-text">Haemoglobin abnormalities</span>
                    </h2>
                    <div class="content-card">
                        <p>This is manifested in Sickle Cell Diseases & Thalassaemia</p>
                        <h3 class="subsection-heading">Structure of Hb</h3>
                        <p>Composed of protein (globin) + haem. The globin consists of two pair of identical polypeptide chains i.e. gamma, alpha, beta, & delta. A normal adult has HbA which has two alpha and two Beta chains. What makes Hb to differ is sequence of amino acid in the chains. There are many other types of Hb e.g. x, c, e, s. etc.</p>
                    </div>
                </section>
                <!-- END: haemoglobin-abnormalities -->

                <!-- START: sickle-cell-disease -->
                <section id="sickle-cell-disease" class="content-section" aria-labelledby="section-heading-3">
                    <h2 id="section-heading-3" class="section-heading">
                         <span class="heading-icon"> </span>
                         <span class="heading-text">SICKLE CELL DISEASE (SCD)</span>
                    </h2>
                    <div class="content-card">
                        <p><strong>DEFINITION:</strong> this is an inherited condition characterized by sickle-shaped red blood cells and chronic hemolysis. This is a severe haemolytic condition resulting from the replacement of the 6th amino acid of the B chain i.e. glutamic acid by valine. This condition is inherited from autosomol dominant mothers. This condition may give rise to homozygous sickle cell disease (ss) or heterozygous sickle cell trait (As).</p>
                        
                        <h3 class="subsection-heading">Geographic distribution</h3>
                        <p>In this country, it is common in;</p>
                        <ul>
                            <li>a) Coast province,</li>
                            <li>b) Nyanza, &</li>
                            <li>c) Western province</li>
                        </ul>

                        <h3 class="subsection-heading">Pathophysiology</h3>
                        <p>The essential fault here is an abnormal Hb in the RBC (Hbss), which causes the red cell to become sickle shaped when the oxygen tension is reduced. Deoxygenation increases blood viscosity. As a result this Rbc become trapped in small blood vessels causing thrombosis with a poor blood flow. This interference of blood flow through arterioles results in infarction and causes death of the tissue involved. Affected organs include spleen, liver.</p>

                        <h3 class="subsection-heading">Crisis</h3>
                        <ol>
                            <li><strong>Thrombotic crisis (painful, vaso occlusive crisis)</strong> this results from occlusion of small blood vessels.</li>
                            <li><strong>Acute chest syndrome.</strong> This may follow on from a vaso-occlusive crisis and is the most common cause of death in adult sickle disease. Bone marrow infarction results in fat emboli in the lungs which cause sickling and infarction leading to ventricular failure if not treated.</li>
                            <li><strong>Sequestration crisis</strong> - seen only in young patients. For unknown reasons large amounts of blood pull in spleen & liver. Thus patient presents with features of circulatory collapse. The TX of sequestration is
                                <ul>
                                    <li>i) Dehydration.</li>
                                    <li>ii) Blood transfusion</li>
                                    <li>iii) If untreated sequestration may lead to death.</li>
                                </ul>
                            </li>
                            <li><strong>Aplastic crisis</strong> - Patient with scd may have transient BM failure. Thus the patient has pancytopenia - this may cause death. The patient has very low Hb which may cause failure. There is low reticulocyte count compared to other sickling crises.</li>
                            <li><strong>Haemolytic crisis</strong>- rare type of crisis but when a SCD patient who may not be having $G B P D$ deficiency and at the same time injecting oxidative drugs e.g chloroquin, quinine, there will be massive haemolysis of red blood cells.</li>
                        </ol>

                        <h3 class="subsection-heading">CLINICAL FEATURES</h3>
                        <p>Depend on what crisis the patient came with; Therefore it will be characteristic i.e.</p>
                        <p><strong>A) Thrombotic crisis (painful crisis)</strong> is characterized by:</p>
                        <ul>
                            <li>i) Dactylitis - most in young people. Severe pain & swelling of the hands & feet</li>
                            <li>ii) Acute abdominal pain because of occlusion of mesenteric artery.</li>
                            <li>iii) Painful bones & joints- this is due to plugging of small vessels in the bone.</li>
                            <li>iv) Stroke may occur due to cerebral vessel occlusion</li>
                            <li>v) Osteomyeclitis - inflammation bones due to salmonella</li>
                            <li>vi) Renal interacts - present with Painless haematuria</li>
                        </ul>
                        <p><strong>B) Acute chest syndrome</strong></p>
                        <ul>
                            <li>i) Chest pain</li>
                            <li>ii) Fever</li>
                            <li>iii) Tachypnoea</li>
                            <li>iv) Wheeze</li>
                            <li>v) cough</li>
                        </ul>
                        <p><strong>C) Sequestration crisis</strong> - there is</p>
                        <ul>
                            <li>i) Circulatory collapse.</li>
                            <li>ii) Splenomegaly</li>
                        </ul>
                        <p><strong>D) Aplastic crisis</strong> - There is</p>
                        <ul>
                            <li>i) Bleeding tendencies - Low platelet count.</li>
                            <li>ii) Recurrent infections - low $WBC$ e.g. pnemococcal meningitis.</li>
                            <li>iii) Anaemia - low $RBC$</li>
                            <li>iv) Fever and general malaise - due to recurrent infections.</li>
                        </ul>
                        <p>Other features include the most general symptoms of anaemia and growth retardation with delayed puberty.</p>

                        <h3 class="subsection-heading">O/E</h3>
                        <ul>
                            <li>i) Sick looking</li>
                            <li>ii) Tachycardia, sweating and a fever - due to systemic response.</li>
                            <li>iii) Jaundiced.</li>
                            <li>iv) Anaemia - pale - haemolysis, sequestration</li>
                            <li>v) Spleenomegally - felt till the age of 6-8 years. The spleen is felt due to spleen autospleenectomy.</li>
                            <li>vi) Chronic leg ulcers.</li>
                            <li>vii) Bossing of the skull.</li>
                            <li>viii) Widened head - comes as a result of widening of parietal & frontal bones.</li>
                            <li>ix) $CNS$ manifestation e.g. paralysis, mental retardation, focal epileptic fits. This is due to poor blood supply to the brain.</li>
                            <li>x) $CVS$ manifestations e.g. tarchycardia, soft systolic murmur, cardiomegally with latter cardiac failure. This comes about as a result of anaemia.</li>
                            <li>xi) Priapism.</li>
                        </ul>
                        <p>Nb The patients are prone to infections due to</p>
                        <ul>
                            <li>i) Thrombotic changes usually leading to necrosis.</li>
                            <li>ii) Autospleenectomy</li>
                            <li>iii) They have a poor pharcocytic function.</li>
                            <li>iv) Common microbes are
                                <ul>
                                    <li>a) salmonella</li>
                                    <li>b) staph aurous.</li>
                                    <li>c) Pneunococci</li>
                                </ul>
                            </li>
                        </ul>

                        <h3 class="subsection-heading">Diagnosis</h3>
                        <p>On basis:-</p>
                        <ul>
                            <li>i) Typical clinical features from the history</li>
                            <li>ii) Details of the geographical origin of the patient.</li>
                            <li>iii) Physical examination.</li>
                            <li>iv) Laboratory support e.g. blood for full haemogram, Hb range $6-8 \mathrm{~g} / \mathrm{dl}$, Reticulocyte count.</li>
                            <li>v) Take blood for; liver function test. Buluribin level will be elevated.</li>
                            <li>vi) Blood for sick ling test will be positive</li>
                            <li>vii) Blood for Hb electrophoresis. This will confirm the diagnosis.</li>
                            <li>viii) In a skull x-ray - show widening of the cranial table.</li>
                        </ul>

                        <h3 class="subsection-heading">Treatment</h3>
                        <p>The treatment is aimed at treatment of symptoms, prevention of sickling episodes and treatment of complications.<br>The Treatment is symptomatic, Treat the symptoms e.g.</p>
                        <ul>
                            <li>i) Rehydrate with Intravenous fluids.</li>
                            <li>ii) Give oxygen by mask if $\mathrm{P}_{\mathrm{a}} \mathrm{O}_{2}$ is low.</li>
                            <li>iii) Adequate Analgesics e.g. opiates., pethidine,</li>
                            <li>iv) Transfusion of cross-matched blood - in severe anaemia.</li>
                            <li>v) Infections - Give antibiotics.</li>
                            <li>vi) Others;
                                <ul>
                                    <li>Exchage transfusion - a patient is simultaneously venesected and transfused to replace Hbs and HbA . This is used in life threatening crises or to prepare patients for surgery.</li>
                                    <li>Allogeneic BM transplants from HLA-matched siblings have been performed but this procedure appears to be potentially curative.</li>
                                    <li>Oral cytotoxic agents e.g. hydroxycarbamide (hydroxyurea) - this drug increases synthesis of HbF . A high HbF Level inhibits formation of HbS , thus reducing sickling.</li>
                                </ul>
                            </li>
                        </ul>
                        <p>Note:- Painful crisis becomes precipited by: infections, dehydration, cold, acidosis, hypoxia. Thus should be treated or avoided.</p>

                        <h3 class="subsection-heading">Management of acute chest syndrome</h3>
                        <ul>
                            <li>i) Bronchodilators e.g salbutamol</li>
                            <li>ii) Antibiotics</li>
                            <li>iii) Oxygen if $\mathrm{P}_{\mathrm{a}} \mathrm{O}_{2}$ is low</li>
                            <li>iv) Red cell transfusion- it improves oxygenation and is effective as exchange transfusion.</li>
                        </ul>

                        <h3 class="subsection-heading">Maintenance treatment</h3>
                        <ul>
                            <li>Folic acid 5 mg . od-></li>
                            <li>Paludrine 100 mg . od-></li>
                            <li>Pen v daily given prophylactically to prevent septicaemia.</li>
                            <li>Hydroxyurea- Inhibition of DNA synthesis thus reduce pain in crisis and reduce anaemia.</li>
                            <li>Immunization - H influenza, Hep B</li>
                            <li>In a good set up - Vaccination against pneumococcus and where available Haemophilus and hepatitis B.</li>
                        </ul>

                        <h3 class="subsection-heading">Prognosis</h3>
                        <p>In Africa few children with sickle-cell anaemia survive to adult life without medical attention.</p>
                        <p>Even with standard medical care appr. 15% die by the age of 20 years and 50% by the age of 40 Years.</p>

                        <h3 class="subsection-heading">Prevention</h3>
                        <ul>
                            <li>Genetic counseling.</li>
                            <li>Prenatal Tests, DNA analysis in the fetal cells. (Amniocentesis.)</li>
                            <li>Parental education can help prevent $90\%$ of deaths from sequestration crisis.</li>
                        </ul>
                        
                        <h3 class="subsection-heading">EMERGENCY MANAGEMENT OF SICKLE CELL CRISIS</h3>
                        <p>This is focused on support of airway,breathing,circulation,pain control and surveillance of complications.</p>
                        <ol>
                            <li><strong>Oxygenation</strong> ;especially for patients with hypoxia and SPO2 of <92%,supplement oxygen atleast at $21 / \mathrm{min}$.</li>
                            <li><strong>Breathing</strong>; ensure the patient is breathing well by assessing the respiratory rates accurately and incase of respiratory failure, intubate</li>
                            <li><strong>Hydration</strong>; with I.V.fluids like $0.9\%$ normal saline and incase of difficulty in i.v access, oral hydration of the patient if can take well orally at $60 \mathrm{mls} / \mathrm{kg} / 24 \mathrm{hrs}$.Ensure close input output monitoring.</li>
                            <li><strong>Pain relief</strong>; within 30 mins of entering the hospital.NSAIDS for mild pains and Morphine as the $1^{\text {st }}$-line analgesic for severe pain at a dose of $0.1 \mathrm{mg} / \mathrm{kg}$ i.v</li>
                            <li><strong>RBC transfusion</strong> in patients with ACS and hemolytic crisis</li>
                            <li><strong>Antibiotics</strong> such as ceftriaxone $1 \mathrm{~g} / 2 \mathrm{~g}$ i.v once daily for 5 days incase of infection or fevers.</li>
                        </ol>

                        <h3 class="subsection-heading">Chronic problems associated with SCD</h3>
                        <ol>
                            <li>Swollen joints, oedema occurs where clots form</li>
                            <li>Exertional dyspnoea, due to increased RBC hemolysis thus reduced oxygen</li>
                            <li>Leg ulcers, clots occlude circulation thus there is irritation of tissues</li>
                            <li>Fatigue, hemolyses of RBCs leads to decreased oxygen supply.</li>
                        </ol>

                        <h3 class="subsection-heading">Complications of SCD</h3>
                        <ol>
                            <li>Chronic obstructive pulmonary disease</li>
                            <li>Heart failure</li>
                            <li>Retinopathy</li>
                            <li>Nephropathy</li>
                            <li>Major organ infaction.</li>
                        </ol>

                        <h3 class="subsection-heading">DDX</h3>
                        <ul>
                            <li>i) Rheumatoid arthritis.</li>
                            <li>ii) Osteomyelitis.</li>
                            <li>iii) Rheumatic fever.</li>
                            <li>iv) Leukemia - the patient has anaemia, bone pain, & bleeding tendencies.</li>
                        </ul>

                        <h3 class="subsection-heading">NURSING DIAGNOSIS</h3>
                        <ol>
                            <li><strong>Impaired gas exchange</strong> Related To Decreased oxygen carrying capacity of blood As Evidenced By dyspnea, cyanosis spo 2 of less than $98\%$</li>
                            <li><strong>Ineffective tissue perfusion</strong> Related To Vaso-occlusive nature of the sickling As Evidenced By delayed capillary refill and diminished peripheral pulses.</li>
                            <li><strong>Acute Pain</strong> Related To Occlusion As Evidenced By Facial grimancing or more generalizedpain and joint swellings</li>
                            <li><strong>Knowledge deficit</strong> Related To lack of exposure As Evidenced By patient's request for information.</li>
                            <li><strong>Risk for fluid volume deficit</strong> Related To increased fluid needs e.g fevers and inflammatory processes.</li>
                        </ol>
                    </div>
                </section>
                <!-- END: sickle-cell-disease -->

                <!-- START: thalassemia -->
                <section id="thalassemia" class="content-section" aria-labelledby="section-heading-4">
                    <h2 id="section-heading-4" class="section-heading">
                         <span class="heading-icon"> </span>
                         <span class="heading-text">Thalassemia</span>
                    </h2>
                    <div class="content-card">
                        <p><strong>Definition:</strong> This is a condition in which there is a deficiency in the synthesis of globin chains of hemoglobin, Thus accumulation of abnormal globin chain within the red cells leads to its early destruction. It's an inherited disorder of haemoglobin synthesis leading to decrease synthesis of either $a$ or $b$ globulin chains.</p>
                        <p>Beta-Thalassemia are caused by deficient synthesis of the B chains and the aThelassaemia is deficient synthesis of the alpha chain. Alpha or beta chains may be affected hence giving rise to either alpha or beta Thalassaemia.</p>
                        <p>Factors contributing to the anemia that occurs in thalassemia are:</p>
                        <ul>
                            <li>i. low intracellular hemoglobin due to the decreased synthesis of the affected chain</li>
                            <li>ii. Continued production and accumulation of the unaffected globin chain.</li>
                        </ul>
                        <p>The reduced hemoglobin synthesis results in a hypochromic, microcytic anemia, whereas the accumulation of the unaffected chain interferes with normal red cell maturation and contributes to membrane changes that lead to hemolysis and anemia.</p>
                        
                        <h3 class="subsection-heading">Signs and symptoms</h3>
                        <p>In thalassemia major the clinical manifestation is as shown:</p>
                        <ul>
                            <li>i. At birth-no symptoms</li>
                            <li>ii. Infants ages 3 to 6 months - pallor; yellow skin and sclera</li>
                            <li>iii. Infants ages 6 to 12 months-severe anemia, bone abnormalities, failure to thrive, and life threatening complications</li>
                            <li>iv. Splenomegaly or hepatomegaly, with abdominal enlargement; frequent infections; bleeding tendencies (especially nose bleeds); anorexia</li>
                            <li>v. Small body, large head (characteristic features); possible mental retardation</li>
                            <li>vi. Facial features similar to Down syndrome in infants, due to thickened bone at the base of the nose from bone marrow hyperactivity</li>
                        </ul>

                        <h3 class="subsection-heading">1. Beta Thalassaemia</h3>
                        <p>The deficient is in the b chains of the hemoglobin. Also known as thalassemia major or cooleys disease. Its characterized by severe anemia, marked hemolysis and ineffective erythropoiesis. With regular blood transfusion therapy, growth and development through childhood is facilitated.</p>
                        <h4 class="subsubsection-heading">Clinical features (children commonly affected)</h4>
                        <p>At birth there are no symptoms but appear later. Infants of age 3-6months presents with pallor, yellow skin and sclera.</p>
                        <ul>
                            <li>i) Growth failure with mental retardation.</li>
                            <li>ii) Severe anaemia.</li>
                            <li>iii) Bone abnormalities</li>
                            <li>iv) Bleeding tendencies</li>
                            <li>v) Frequent infections</li>
                            <li>vi) Anorexia</li>
                            <li>vii) Abdominal enlargement</li>
                            <li>viii) Facial features similar to down syndrome in infants due to thickened bones at the base of the nose from bone marrow hyper activity.</li>
                            <li>ix) Intermittent infection</li>
                            <li>x) A bossing of head</li>
                            <li>xi) Hepatomegaly and splenomegaly.</li>
                            <li>xii) Blood for a full haemogram show:- low; Hb, MCV, MCH, & high reticulocyte count. WBC & Platelets are normal.</li>
                            <li>xiii) Diagnosis's is confirmed by the electrophoresis.</li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">Investigations</h4>
                        <ol>
                            <li><strong>CBC and PBF</strong>
                                <ul>
                                    <li>-Hb ranges from $2-8 \mathrm{~g} / \mathrm{dl}$ in severe form</li>
                                    <li>-MCV and MCH are low</li>
                                    <li>-WBCs elevated in Beta thalassaemia</li>
                                </ul>
                            </li>
                            <li><strong>HB electrophoresis</strong></li>
                            <li><strong>Iron studies ie serum ferritin level.</strong></li>
                            <li><strong>imaging sturdies</strong>
                                <ul>
                                    <li>- CXR - cardiac size and shape</li>
                                    <li>- MRI</li>
                                    <li>- CT scan</li>
                                    <li>-Skeleton survey- widening of the skull bones</li>
                                </ul>
                            </li>
                            <li><strong>Liver biopsy</strong></li>
                            <li><strong>Bone marrow aspiration</strong></li>
                        </ol>
                        <p>Nb : these features are seen in thalassaemia major. Thelassaemia minor is usually asymptomatic. No Rx is given in thelassaemia minor.</p>
                        
                        <h4 class="subsubsection-heading">Rx - Thalassaemia major</h4>
                        <ul>
                            <li>Folic acid</li>
                            <li>Regular blood transfusion</li>
                            <li>Vitamin E supplement 1. iu/kg/day po</li>
                            <li>Ascorbic acid $3 \mathrm{mg} / \mathrm{kg} /$ day po</li>
                            <li>Vaccination with hemophillus and influenza</li>
                            <li>Pain management- acetaminophen $10-15 \mathrm{mg}$</li>
                            <li>Counseling on the condition.</li>
                        </ul>

                        <h3 class="subsection-heading">2. Alpha Thalassaemia</h3>
                        <p>This is reduction or absence of alpha chain synthesis.<br>a) Heterozygous alpha thalassaemia<br>b) Homozygous alpha thalassaemia.</p>
                        <h4 class="subsubsection-heading">Heterozygous alpha thalassaemia</h4>
                        <ul>
                            <li>-Alpha chains are adequate</li>
                            <li>-survives up to adult life.</li>
                        </ul>
                        <h4 class="subsubsection-heading">Homozygous alpha thalassaemia</h4>
                        <ul>
                            <li>-The reduction or absence of alpha chain synthesis is common in S.E Asia.</li>
                            <li>- Alpha gene loci have four genes.</li>
                            <li>- If one is deleted there is no clinical effect</li>
                            <li>- If two are deleted the patient may have mild hypochromic anaemia</li>
                            <li>- If three are deleted the patient will have HbF disease</li>
                            <li>- If four are deleted the baby is stillborn (Hyrops Fetalis)</li>
                            <li>-it is Incompatable with life.</li>
                            <li>-Children born are still births or die shortly after they are born.</li>
                        </ul>
                        <p><strong>O/E</strong></p>
                        <ul>
                            <li>a) Pale</li>
                            <li>b) Edematous</li>
                            <li>c) Large liver or spleen.</li>
                        </ul>
                        <p>The above conditions are collectively called hydrops fitalis.</p>

                        <h3 class="subsection-heading">Treatment</h3>
                        <h4 class="subsubsection-heading">Beta thalassaemia</h4>
                        <ul>
                            <li><strong>For erythropoietic failure</strong>
                                <ul>
                                    <li>Allogeneic bone marrow transplantation from human leucocyte antigen (HLA)-compatible sibling</li>
                                    <li>Transfusion to maintain $\mathrm{Hb}>10 \mathrm{~g} / \mathrm{dl}$</li>
                                </ul>
                            </li>
                            <li><strong>For iron over load - iron is contraindicated</strong>
                                <ul>
                                    <li>Iron therapy is forbidden</li>
                                    <li>Give Desferrioxamine therapy</li>
                                </ul>
                            </li>
                        </ul>
                        <p>Iron overload is a major complication of $\beta$-thalassemia. Excess iron stores, which accumulate from increased dietary absorption and repeated transfusions, are deposited in the myocardium, liver, and endocrine organs and induce organ damage. Regular blood transfusions to maintain hemoglobin levels at 9 to $10 \mathrm{~g} / \mathrm{dL}$ improve growth and development and prevent most of the complications, and iron chelation therapy can reduce the iron overload and extend life expectancy</p>
                    </div>
                </section>
                <!-- END: thalassemia -->

                <!-- START: immune-haemolytic-anaemia -->
                <section id="immune-haemolytic-anaemia" class="content-section" aria-labelledby="section-heading-5">
                    <h2 id="section-heading-5" class="section-heading">
                         <span class="heading-icon"> </span>
                         <span class="heading-text">Immune haemoltic anaemia</span>
                    </h2>
                    <div class="content-card">
                        <p>Are in two types:<br>a) Iso-immune.<br>b) Auto-immune.</p>

                        <h3 class="subsection-heading">1. Auto-immune haemolytic anaemia</h3>
                        <p>This is an acquired disorder in which the body produces antibodies against its own cells. Antibodies binds to the patients RCs then are pharcocytosed & removed from circulation by macrophages.</p>
                        <h4 class="subsubsection-heading">Causes</h4>
                        <p>Idiopathic<br>Few secondary causes</p>
                        <ul>
                            <li>a) Drugs e.g. methyldopa.</li>
                            <li>b) Autoimmune diseases e.g. rheumatoid arthritis and systematic lupus erythematosis.</li>
                            <li>c) Lymphomas and other malignancies</li>
                            <li>d) Chronic lymphocytic leukemia.</li>
                        </ul>

                        <h4 class="subsubsection-heading">C/F</h4>
                        <p>Signs and symptoms of anaemia.</p>
                        <h4 class="subsubsection-heading">O/E</h4>
                        <ul>
                            <li>i) pale</li>
                            <li>ii) jaundice</li>
                            <li>iii) splenolomgaly</li>
                            <li>iv) hepatomegaly may or may not be there</li>
                        </ul>

                        <h4 class="subsubsection-heading">DX</h4>
                        <ul>
                            <li>i) Blood for coombs test.</li>
                        </ul>
                        <h5 style="font-weight: 600;">Direct coombs test</h5>
                        <p>Coombs reagent is added to the blood. If the Rbc surfaces was covered with Ab then agglutination will occur.</p>
                        <h5 style="font-weight: 600;">Indirect coombs</h5>
                        <p>This help to detect free Ab in the blood serum. Usually this is done when direct coombs test is negative & still suspect the patient has autoimmune haemolytic anaemia.</p>
                        <h5 style="font-weight: 600;">Technique</h5>
                        <p>Mix the blood of two individuals who have compatible blood. This will help to incubate antibodies. Then perform the test on the blood as in direct coomb's test. If agglutination occurs, then indirect coomb's test Is positive.</p>
                        
                        <h4 class="subsubsection-heading">Treatment</h4>
                        <ol>
                            <li>Give steroids e.g. prednisone 60 mg then taper.</li>
                            <li>Transfusion may or may not be done</li>
                            <li>If cause is identified then treat.</li>
                        </ol>

                        <h3 class="subsection-heading">Iso-immune haemolytic anaemia</h3>
                        <p>In this anaemia antibodies produced by one individual reacts with red cells of another.</p>
                    </div>
                </section>
                <!-- END: immune-haemolytic-anaemia -->

                <!-- START: aplastic-anaemia -->
                <section id="aplastic-anaemia" class="content-section" aria-labelledby="section-heading-6">
                    <h2 id="section-heading-6" class="section-heading">
                         <span class="heading-icon"> </span>
                         <span class="heading-text">Anemia due to BM Failure (aplastic anaemia)</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Definition</h3>
                        <p>This is aplasia of BM with subsequent peripheral pancytophenia (low WBC,RBC, platelets.)</p>
                        
                        <h3 class="subsection-heading">Mechanism</h3>
                        <p>Occurs due to destruction of primitive stem cells together with a fault in differentiation. As a result all the peripheral blood cell components are reduced.</p>

                        <h3 class="subsection-heading">Causes</h3>
                        <ul>
                            <li>a) Idiopathic,</li>
                            <li>b) Congenital,</li>
                            <li>c) Acquired,
                                <ul>
                                    <li>i) Drugs e.g. antibiotics; like chloramphenical, sulphanomides: cytotixic drugs, phenylbutazone: anti thyroid drugs:anticonvulsants:immunosuppressive drugs e.g. azathioprine</li>
                                    <li>ii) Chemicals e.g. -benzene toluent solvent misuse - glue sniffing.
                                        <ul>
                                            <li>-Insecticides - chlorinated hydrocarbons (DDT),</li>
                                            <li>-Organophosphates</li>
                                        </ul>
                                    </li>
                                    <li>ii) Infections like measles, viral hepatitis</li>
                                </ul>
                            </li>
                            <li>d) pregnancy</li>
                            <li>e) radiations e.g. x-rays or radiotherapy</li>
                            <li>f) Paroxismal nocturnal haemoglobinuria</li>
                        </ul>

                        <h3 class="subsection-heading">C/F</h3>
                        <ol>
                            <li>features of anaemia</li>
                            <li>Frequent infections</li>
                            <li>Bleeding tendency - skin, mucus membrane</li>
                        </ol>
                        
                        <h3 class="subsection-heading">O/E</h3>
                        <ol>
                            <li>may or may not have lymphodenopathy</li>
                            <li>ecchymosis</li>
                            <li>bleeding gums</li>
                            <li>mouth sores</li>
                            <li>oral candidiasis</li>
                            <li>throat infection</li>
                            <li>Evidence of infection in any other part of the body.</li>
                        </ol>

                        <h3 class="subsection-heading">Investigation</h3>
                        <ol>
                            <li>Blood for a full haemogram - normocytic normochromic anaemia, low platelet count, low WBC, no reticulocyte.</li>
                            <li>Bone marrow aspirate and trephine - shows a hypocellular BM i.e. reduced cell in the Bm .</li>
                        </ol>

                        <h3 class="subsection-heading">DDX</h3>
                        <ol>
                            <li>Other conditions that cause pancytopenia i.e. disseminated TB</li>
                            <li>hypersplenism</li>
                            <li>megaloplastic anaemia.</li>
                            <li>Bone marrow infiltration by malignant cells.</li>
                        </ol>

                        <h3 class="subsection-heading">Treatment</h3>
                        <p>Treat or remove the cause</p>
                        <ul>
                            <li>a) Supportive care
                                <ul>
                                    <li>- Frequent transfusion till remission.</li>
                                    <li>- Treat any infection</li>
                                    <li>- Steroids may be used to reduce the bleeding</li>
                                </ul>
                            </li>
                            <li>b) Heamatopoiesis stimulants
                                <p>Androgenic asteroids eg oxymetholone. Orally 100 mg odx $6 / 12$ androgen is able to raise erythropoietin to high serum level. Also may raise responsiveness of erythroid precursors to erythropoietin</p>
                                <h4 class="subsubsection-heading">S/E of oxymetholone</h4>
                                <ul>
                                    <li>i) It is an androgenic predominant.</li>
                                    <li>ii) Causes high lbids</li>
                                    <li>iii) Fluid retention.</li>
                                    <li>iv) Gives abnormal LFT parameters</li>
                                </ul>
                            </li>
                            <li>c). BM transplant if no remission to (a&b) treatment.</li>
                        </ul>

                        <h3 class="subsection-heading">Prognosis</h3>
                        <ul>
                            <li>- Spontaneous remission with recovery.</li>
                            <li>- Progressive severe deficiency of all components of blood leading to death due to infections or haemorrhage.</li>
                            <li>- Bad prognostic features
                                <ul>
                                    <li>- neutrophil count <0.4 x 10<sup>9</sup>/1.</li>
                                    <li>- platelets count <20 X 10<sup>9</sup>/l.</li>
                                    <li>- reticulocyte <0.1%.</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: aplastic-anaemia -->
            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="hematology-anaemias.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 57%;"></div> <!-- Set percentage dynamically -->
                        </div>
                       <span class="progress-text">Lecture 4 of 7</span> <!-- Update text -->
                    </div>
                    <a href="hematology-bleeding-disorders.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>